Study Group: Securities, Corporate Governance, and M&A Experts: Lawyers (Asia)
Council Members in this Study Group: 304
This study group may include professors, attorneys, former regulatory officers, and consultants knowledgeable on topics such as law and litigation issues, lobbying, policy and government, elections, antitrust, immigration, intellectual property, and legislation, among others.
Contact Gerson Lehrman Group to survey or consult with members of this Study Group
Leading institutions connect with members of this Study Group through GLG
Leading Experts in this Study Group
- Matthew Murphy
Managing Director
MMLC Group
Matthew Murphy is the Managing Director of the MMLC Group in Beijing. Prior to founding the MMLC Group, Mr. Murphy was part of the China and M&A teams at Freshfields Bruckhaus Deringer and led the Asian IP/IT group out of Hong Kong. He specializes in...
Andrew LipmanPartner & Chair, Telecom, Media & Technology
BINGHAM MCCUTCHEN LLPAndrew D. Lipman is Partner and Chair of the Telecommunications, Media and Technology Practice Group at Bingham McCutchen in Washington, DC. He specializes in communications law and related fields, including regulatory, transactional, litigation, legislative...
Rachel LaundersPartner
Gilbert & Tobin LawyersRachel Launders is a Partner in the Corporate Transactions Group at Gilbert + Tobin in Sydney, Australia, where she specializes in mergers and acquisitions (M&A). Specifically, Ms. Launders advises on and structures privatizations, joint ventures, business...
John DouglasPartner
DAVIS POLK & WARDWELLJohn Douglas is a partner in the Financial Institutions Group at Davis Polk, heading the firm’s bank regulatory practice and focusing on bank restructuring and resolutions and other issues arising from the current banking and financial crisis. He has...
- Mark Saunders
Former General Counsel
WR Capital Management, LPMark Saunders was until April 1, 2009, the General Counsel of WR Capital Management. Previously, Mr. Saunders was a Senior Partner in the New York office of a law firm with over 1,000 lawyers, in which office he practiced for 19 years. He practices in...
GLG NewsSM Analyses by this Study Group's Leading Experts(?)
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
-
China's Anti-Monopoly Bureau Approves the Panasonic-Sanyo Transaction
November 11, 2009
Analysis by: Matthew Murphy, Managing Director,China's Anti-Monopoly Bureau Approves the Panasonic-Sanyo Transaction | www.mmlcgroup.com
The Chinese Anti-Monopoly Bureau (AMB) handed down its decision in early November 2009, regarding Panasonic’s acquisition of Sanyo. The AMB approved the transaction subject to divestiture of certain assets. The decision is more comprehensive that previous decisions, although this case was the first to go into a third phase of investigation by the AMB indicating the complications involved.
-
The Regulation of Online Games in China
October 30, 2009
Analysis by: Matthew Murphy, Managing Director,The Regulation of Online Games in China | www.mmlcgroup.com
The online games industry in China is becoming incredibly profitable, with millions of regular users and an endless thirst for new games and technology. This article looks at the regulations and departments in China that are claiming authority to regulate this space. As expected there is considerable room for improvement, however the regulatory environment is beginning to take shape.
-
China’s Anti-Monopoly Bureau Approves the Pfizer-Wyeth Transaction
September 29, 2009
Analysis by: Matthew Murphy, Managing Director,China’s Anti-Monopoly Bureau Approves the Pfizer/Wyeth Transaction | www.mmlcgroup.com
On 29 September 2009, China’s Ministry of Commerce (“MOFCOM”) published another decision from its fledgling Anti-Monopoly Bureau (“AMB”), this time concerning the acquisition of Wyeth by US drug heavy-weight, Pfizer. Approval was granted to the transaction, ahead of approval from the US Federal Trade Commission, Australian ACCC and the Canadian Competition authority.
-
ASIC v. James Hardie - the spotlight on company directors and senior management
June 2, 2009
Analysis by: Rachel Launders, Partner,James Hardie proceedings | www.asic.gov.au
Directors in Australian listed companies may be nervous about the duty of care which they owe to the company, following the decision in ASIC v. James Hardie (April 2009). The Court found that they have a duty to avoid exposing the company to risk of harm to reputation or legal claims. Senior executives, including the General Counsel, also came under the spotlight, being found in breach of their duties for failing to warn the board of the risks which the company was being exposed to. The case is also a reminder that companies need to take particular care with public announcements - the desire to promote the good news cannot overtake the need for an announcement which is balanced, objective, complete and accurate.
-
April 27, 2009
Analysis by: Matthew Murphy, Managing Director,China’s New Anti-Monopoly Law – an analysis of recent decisions regarding foreign investment and trade | www.mmlcgroup.com
The new Chinese Anti-Monpoly Bureau ("AMB") has issued a number of controversial decisions in recent months, involving intenational M&A transactions. It has approved most transactions, although many on a conditional basis, but it refused to approve the greatly followed Coca Cola acquisition of Huiyuan. This article looks at the law, the criteria applied by the AMB, the facts and decision issued in a number of cases, and provides guidelines that companies should look at prior to approaching the AMB for approval.
Members in this Study Group include these company types:
- Law Firm (general practice/large)
- Law Firm (Boutique / Specialized)
- Law firm (small / solo)
- Academic Institution*
Members in this Study Group often have these job titles:
- Partner
- Attorney
- Associate